Drugs / Seasonal Trivalent Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00976469 | Sep 2009 → Apr 2010 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04515368 | Jun 2016 → Sep 2020 | — | Imperial College London | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal trivalent influenza vaccine | “Seasonal Trivalent Influenza Vaccine ('ÄòSTIV'Äô, split virion inactivated, Northern Hemisphere 2016-17, Sanofi Pasteur); 0.5 mL. intramuscular. stat.” NCT04515368 ↗ |
| Known as | STIV | “Seasonal Trivalent Influenza Vaccine ('ÄòSTIV'Äô, split virion inactivated, Northern Hemisphere 2016-17, Sanofi Pasteur)” NCT04515368 ↗ |
| Modality | Vaccine | “licensed trivalent seasonal (2010/2011) influenza vaccine” PMID 22846396 ↗ Jul 2012 |